Ling Xu

14PUBLICATIONS
42CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 22, 2026
CD69 blockade restores the bone marrow niche and delays leukemogenesis in a mouse model of Nras G12D-driven chronic myelomonocytic leukemia.

|Jan 18, 2024
Inhibition of NRF2 enhances the acute myeloid leukemia cell death induced by venetoclax via the ferroptosis pathway.

Xibao Yu, Yan Wang, Jiaxiong Tan

|Jan 15, 2024
CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer.

Yuchen Li, Yinfeng Gu, Pengyue Yang

|Sep 05, 2023
Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy.

Letong Cai, Yuchen Li, Jiaxiong Tan

|Nov 25, 2022
Identification of TCR rearrangements specific for genetic alterations in EGFR-mutated non-small cell lung cancer: results from the ADJUVANT-CTONG1104 trial.

Cunte Chen, Siyang Maggie Liu, Yedan Chen

|May 11, 2022
Correlation of the transcription factors IRF4 and BACH2 with the abnormal NFATC1 expression in T cells from chronic myeloid leukemia patients.

Yikai Zhang, Xiangbo Zeng, Xianfeng Zha

Pageof 3

Frequent Collaborators

13 joint publications

Yangqiu Li

4 joint publications

Zhenyi Jin

4 joint publications

Shaohua Chen

4 joint publications

Yikai Zhang